RIPK1 and head and neck squamous cell carcinoma: In head and neck squamous cell carcinoma, USP4 inhibits carcinogenesis by deubiquitinating receptor-interacting protein 1 (RIP1) and promoting apoptosis induced by tumour necrosis factor-α (TNF-α) (48).